跳至主要内容
临床试验/CTRI/2024/12/078073
CTRI/2024/12/078073尚未招募3 期

Efficacy of Dhananjaya Vati in the management of Kaphaja Kasa – A randomised controlled clinical trial

Dr Yashas M1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Assessment of Kasa with Bahula, Madhura, Snigdha, Ghana Kapha nishteevana

研究概览

简要总结

This study is a randomised, single blind, parallel group, actively controlled comparative clinical study comparing the efficacy of Dhananjaya Vati and Lavangadi Vati with a dosage of two tablets of 250mg each at every 2 hours for 7 days in 60 patients with Kaphaja Kasa that will be conducted at Alvas Ayurveda Medical College and Hospital. The primary outcome measures will be Kasa with Bahula, Madhura, Snigdha, Ghana Kapha nishteevana and Bronchitis Severity Scale at 0, 4, 8 and 15 days. The secondary outcome measures will be TC, DC, ESR and AEC at at 0, 4, 8 and 15 days.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Subjects with onset less than 3 weeks
  • Subjects who are ready to give written informed consent.
  • Subjects fulfilling the diagnostic criteria.

排除标准

  • Subjects with other systemic and metabolic diseases
  • Subjects undergoing steroid therapies which may interfere with the course of treatment
  • Subjects suffering from chronic respiratory conditions
  • Subjects with antibiotic use in the preceding two weeks
  • Pregnant women and lactating mothers.

结局指标

主要结局

Assessment of Kasa with Bahula, Madhura, Snigdha, Ghana Kapha nishteevana

时间窗: Day 0, Day 4, Day 8, Day 15

次要结局

  • Assessment of TC, DC, ESR, AEC(Day 0, Day 4, Day 8, Day 15)

研究者

发起方
Dr Yashas M
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Yashas M

Alvas Ayurveda Medical College and Hospital

研究点 (1)

Loading locations...

相似试验